The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease ; volume:13 ; number:1 ; day:28 ; month:5 ; year:2024 ; pages:1-5 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (28.5.2024), 1-5, 12.2024

Creator
Wang, Yi-Ting
Ashton, Nicholas J.
Servaes, Stijn
Nilsson, Johanna
Woo, Marcel S.
Pascoal, Tharick A.
Tissot, Cécile
Rahmouni, Nesrine
Therriault, Joseph
Lussier, Firoza
Chamoun, Mira
Gauthier, Serge
Brinkmalm, Ann
Zetterberg, Henrik
Blennow, Kaj
Rosa-Neto, Pedro
Benedet, Andréa L.
Contributor
SpringerLink (Online service)

DOI
10.1186/s40035-024-00420-1
URN
urn:nbn:de:101:1-2408060953511.376574591741
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:04 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Wang, Yi-Ting
  • Ashton, Nicholas J.
  • Servaes, Stijn
  • Nilsson, Johanna
  • Woo, Marcel S.
  • Pascoal, Tharick A.
  • Tissot, Cécile
  • Rahmouni, Nesrine
  • Therriault, Joseph
  • Lussier, Firoza
  • Chamoun, Mira
  • Gauthier, Serge
  • Brinkmalm, Ann
  • Zetterberg, Henrik
  • Blennow, Kaj
  • Rosa-Neto, Pedro
  • Benedet, Andréa L.
  • SpringerLink (Online service)

Other Objects (12)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration

Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study

Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer’s disease, and neuronal injury in humans: a cohort study

Related objects